Small But Increasingly Mighty: Latest Advances in AAV Vector Research, Design, and Evolution

被引:97
作者
Grimm, Dirk [1 ,2 ,3 ]
Buening, Hildegard [4 ,5 ,6 ,7 ]
机构
[1] Heidelberg Univ Hosp, Dept Infect Dis, Cluster Excellence CellNetworks, Virol, Heidelberg, Germany
[2] Heidelberg Univ, BioQuant Ctr, Heidelberg, Germany
[3] Partner Site Heidelberg, German Ctr Infect Res DZIF, Heidelberg, Germany
[4] Hannover Med Sch, Inst Expt Hematol, Hannover, Germany
[5] Hannover Med Sch, Cluster Excellence REBIRTH, Hannover, Germany
[6] Partner Site Hannover Braunschweig, German Ctr Infect Res DZIF, Hannover, Germany
[7] Univ Cologne, Ctr Mol Med Cologne, Cologne, Germany
关键词
AAV; adeno-associated virus; molecular evolution; virus engineering; immune escape; virus-host interaction; ADENOASSOCIATED VIRAL VECTORS; GENE-THERAPY VECTOR; IN-VITRO; VIRUS-INFECTION; TRANSDUCTION; IDENTIFICATION; SELECTION; RECEPTOR; IMPACT; PLASMAPHERESIS;
D O I
10.1089/hum.2017.172
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Recombinant gene delivery vectors derived from naturally occurring or genetically engineered adeno-associated viruses (AAV) have taken center stage in human gene therapy, fueled by rapidly accumulating and highly encouraging clinical data. Nonetheless, it has also become evident that the current generation of AAV vectors will require improvements in transduction potency, antibody evasion, and cell specificity in order to realize their full potential and to widen applicability in larger patient cohorts. Fortunately, in the recent past, the field has seen a flurry of exciting new developments that enhance our understanding of AAV vector biology, including virus-host interactions, and/or that expand our arsenal of technologies for AAV capsid design and evolution. This review highlights a collection of latest advances in these areas, which, in the authors' opinion, hold particular promise to propel the AAV vector field forward in the near future, especially when applied in combination. These include fundamental novel insights into the AAV life cycle, from an unexpected role of autophagy and interactions with other viruses to the (re-)discovery of a universal AAV receptor and the function of AAV-AAP for capsid assembly. Concurrently, recent successes in the rational design of next-generation synthetic AAV capsids are pointed out, exemplified by the structure-guided derivation of AAV mutants displaying robust in vivo immune evasion. Finally, a variety of new and innovative strategies for high-throughput generation and screening of AAV capsid libraries are briefly reviewed, including Cre recombinase-based selection, ancestral AAV capsid reconstruction, and DNA barcoding of AAV genomes. All of these examples showcase the present momentum in the AAV field and, together with work by many other academic or industrial entities, raise substantial optimism that the remaining hurdles for human gene therapy with AAV vectors will (soon) be overcome.
引用
收藏
页码:1075 / 1086
页数:12
相关论文
共 77 条
  • [21] Naturally enveloped AAV vectors for shielding neutralizing antibodies and robust gene delivery in vivo
    Gyoergy, Bence
    Fitzpatrick, Zachary
    Crommentuijn, Matheus H. W.
    Mu, Dakai
    Maguire, Casey A.
    [J]. BIOMATERIALS, 2014, 35 (26) : 7598 - 7609
  • [22] Autophagy Determines Efficiency of Liver-Directed Gene Therapy With Adeno-Associated Viral Vectors
    Hoesel, Marianna
    Huber, Anke
    Bohlen, Susanne
    Lucifora, Julie
    Ronzitti, Giuseppe
    Puzzo, Francesco
    Boisgerault, Florence
    Hacker, Ulrich T.
    Kwanten, Wilhelmus J.
    Kloeting, Nora
    Blueher, Matthias
    Gluschko, Alexander
    Schramm, Michael
    Utermoehlen, Olaf
    Bloch, Wilhelm
    Mingozzi, Federico
    Krut, Oleg
    Buening, Hildegard
    [J]. HEPATOLOGY, 2017, 66 (01) : 252 - 265
  • [23] Hepatitis B Virus Infection Enhances Susceptibility Toward Adeno-Associated Viral Vector Transduction In Vitro and In Vivo
    Hoesel, Marianna
    Lucifora, Julie
    Michler, Thomas
    Holz, Gisela
    Gruffaz, Marion
    Stahnke, Stephanie
    Zoulim, Fabien
    Durantel, David
    Heikenwalder, Mathias
    Nierhoff, Dirk
    Millet, Rachel
    Salvetti, Anna
    Protzer, Ulrike
    Buening, Hildegard
    [J]. HEPATOLOGY, 2014, 59 (06) : 2110 - 2120
  • [24] Toll-like receptor 2-mediated innate immune response in human nonparenchymal liver cells toward adeno-associated viral vectors
    Hoesel, Marianna
    Broxtermann, Mathias
    Janicki, Hanna
    Esser, Knud
    Arzberger, Silke
    Hartmann, Pia
    Gillen, Sonja
    Kleeff, Joerg
    Stabenow, Dirk
    Odenthal, Margarete
    Knolle, Percy
    Hallek, Michael
    Protzer, Ulrike
    Buening, Hildegard
    [J]. HEPATOLOGY, 2012, 55 (01) : 287 - 297
  • [25] Exosome-associated AAV vector as a robust and convenient neuroscience tool
    Hudry, E.
    Martin, C.
    Gandhi, S.
    Gyorgy, B.
    Scheffer, D. I.
    Mu, D.
    Merkel, S. F.
    Mingozzi, F.
    Fitzpatrick, Z.
    Dimant, H.
    Masek, M.
    Ragan, T.
    Tan, S.
    Brisson, A. R.
    Ramirez, S. H.
    Hyman, B. T.
    Maguire, C. A.
    [J]. GENE THERAPY, 2016, 23 (04) : 380 - 392
  • [26] High Prevalence of Infectious Adeno-associated Virus (AAV) in Human Peripheral Blood Mononuclear Cells Indicative of T Lymphocytes as Sites of AAV Persistence
    Hueser, Daniela
    Khalid, Dina
    Lutter, Timo
    Hammer, Eva-Maria
    Weger, Stefan
    Hessler, Melanie
    Kalus, Ulrich
    Tauchmann, Yvonne
    Hensel-Wiegel, Karin
    Lassner, Dirk
    Heilbronn, Regine
    [J]. JOURNAL OF VIROLOGY, 2017, 91 (04)
  • [27] Enhancement of Adeno-Associated Virus Infection by Mobilizing Capsids into and Out of the Nucleolus
    Johnson, Jarrod S.
    Samulski, R. Jude
    [J]. JOURNAL OF VIROLOGY, 2009, 83 (06) : 2632 - 2644
  • [28] An Experimental and Computational Evolution-Based Method to Study a Mode of Co-evolution of Overlapping Open Reading Frames in the AAV2 Viral Genome
    Kawano, Yasuhiro
    Neeley, Shane
    Adachi, Kei
    Nakai, Hiroyuki
    [J]. PLOS ONE, 2013, 8 (06):
  • [29] Engineering and Evolution of Synthetic Adeno-Associated Virus (AAV) Gene Therapy Vectors via DNA Family Shuffling
    Kienle, Eike
    Sens, Elena
    Boerner, Kathleen
    Niopek, Dominik
    Wiedtke, Ellen
    Grosse, Stefanie
    Grimm, Dirk
    [J]. JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2012, (62):
  • [30] Optimization of design and production strategies for novel adeno-associated viral display peptide libraries
    Koerbelin, J.
    Hunger, A.
    Alawi, M.
    Sieber, T.
    Binder, M.
    Trepel, M.
    [J]. GENE THERAPY, 2017, 24 (08) : 470 - 481